Cargando…

Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies

INTRODUCTION: Considering the reported efficacy of monoclonal antibodies (mAbs) directed against the Spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in reducing disease severity, the aim of this study was to investigate the innate immune response before and after mA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maddaloni, Luca, Santinelli, Letizia, Bugani, Ginevra, Cacciola, Elio G., Lazzaro, Alessandro, Lofaro, Chiara M., Caiazzo, Sara, Frasca, Federica, Fracella, Matteo, Ajassa, Camilla, Leanza, Cristiana, Napoli, Anna, Cinti, Lilia, Gaeta, Aurelia, Antonelli, Guido, Ceccarelli, Giancarlo, Mastroianni, Claudio M., Scagnolari, Carolina, d'Ettorre, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571496/ https://www.ncbi.nlm.nih.gov/pubmed/37904704 http://dx.doi.org/10.1002/iid3.968

Ejemplares similares

Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
por: Sorrentino, Leonardo, et al.
Publicado: (2023)

Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort
por: Lazzaro, Alessandro, et al.
Publicado: (2023)

Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
por: Santinelli, Letizia, et al.
Publicado: (2023)

Health-related quality of life in survivors of severe COVID-19 infection
por: d’Ettorre, Gabriele, et al.
Publicado: (2022)

Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
por: Trinchieri, Vito, et al.
Publicado: (2022)

Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19
por: Sorrentino, Leonardo, et al.
Publicado: (2022)

High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
por: Scordio, Mirko, et al.
Publicado: (2022)

Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report
por: d’Ettorre, Gabriella, et al.
Publicado: (2020)

Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial
por: Innocenti, Giuseppe P., et al.
Publicado: (2020)

Probiotics and COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
por: Santinelli, Letizia, et al.
Publicado: (2020)

Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
por: Frasca, Federica, et al.
Publicado: (2022)

Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2019)

Antiretroviral Therapy Dampens Mucosal CD4(+) T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1
por: Lazzaro, Alessandro, et al.
Publicado: (2021)

Efficacy of Remdesivir-Containing Therapy in Hospitalized COVID-19 Patients: A Prospective Clinical Experience
por: Russo, Alessandro, et al.
Publicado: (2021)

Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients
por: Santinelli, Letizia, et al.
Publicado: (2021)

Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω
por: Pierangeli, Alessandra, et al.
Publicado: (2022)

Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort
por: Lazzaro, Alessandro, et al.
Publicado: (2021)

The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review
por: Lazzaro, Alessandro, et al.
Publicado: (2022)

Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
por: Cavallari, Eugenio Nelson, et al.
Publicado: (2021)

Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation
por: Pinacchio, Claudia, et al.
Publicado: (2018)

Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects
por: De Angelis, Massimiliano, et al.
Publicado: (2019)

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
por: d’Ettorre, Gabriele, et al.
Publicado: (2021)

Is previous influenza-like illness a potential Trojan horse for COVID-19?
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone
por: Russo, Alessandro, et al.
Publicado: (2022)

Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients
por: Antonelli, Guido, et al.
Publicado: (2020)

Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic
por: Russo, Alessandro, et al.
Publicado: (2021)

The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults
por: Oliveto, Giuseppe, et al.
Publicado: (2022)

Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)
por: Scagnolari, Carolina, et al.
Publicado: (2021)

Clinical Characteristics and Outcome of Patients with Suspected COVID-19 in Emergency Department (RESILIENCY Study II)
por: Russo, Alessandro, et al.
Publicado: (2021)

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease
por: Esposito, Antonella, et al.
Publicado: (2011)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Anti-N SARS-CoV-2 assays for evaluation of natural viral infection
por: Gaeta, Aurelia, et al.
Publicado: (2023)

Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action
por: d'Ettorre, Gabriele, et al.
Publicado: (2022)

Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?
por: Bellelli, Valeria, et al.
Publicado: (2020)

Purulent Meningitis as an Unusual Presentation of Staphylococcus aureus Endocarditis: A Case Report and Literature Review
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

Dysbiosis in SARS-CoV-2–Infected Patients
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9lfa1einsk03bsd0lo2771397j